(PRWEB) September 23, 2013
The Corporate Whistleblower Center says, "Rewards for whistleblowers in pharmaceutical companies can be staggering. According to a May 13th 2013 Department of Justice press release, Ranbaxy USA, a generic drug manufacturer and subsidiary of Ranbaxy Laboratories Limited in England, plead guilty and agreed to pay a $500 million fine for their alleged involvement in manufacturing and distributing adulterated drugs. Adulterated drugs are drugs that are manufactured, processed, or packaged in facilities that do not conform to current Good Manufacturing Practices. The FDA prohibits the introduction or delivery of these types of drugs."
The Corporate Whistleblower Center says, “The FDA holds pharmaceutical companies to the highest standards regarding the manufacture and distribution of prescription drugs, both name brand and generic. As we can see from the Ranbaxy case, fines and charges for allegedly violating these laws are significant. For whistleblowers, this means rewards are just as substantial. The whistleblower in the Ranbaxy case received $48.6 million from the settlement.”
The Corporate Whistleblower Center is urging pharmaceutical company insiders with proof of a company selling adulterated drugs to contact them anytime at 866-714-6466 for more information about a potential reward programs. All information is kept completely confidential. If the proof of wrongdoing is well documented, the Corporate Whistleblower Center will get the possible whistleblower to nations premier whistleblower attorneys, with the goal being the best possible reward. http://CorporateWhistleblowerCenter.Com
Simple rules for a whistleblower from the Corporate Whistleblower Center:
The Corporate Whistleblower Center wants to emphasize there are high quality whistleblowers in every state including California, New York, Florida, Texas, Massachusetts, Maryland, Virginia, Ohio, Pennsylvania, Tennessee, North Carolina, Georgia, Alabama, Louisiana, Missouri, Michigan, Iowa, Indiana, Illinois, Wisconsin, Minnesota, North Dakota, Nebraska, Kansas, Colorado, Utah, New Mexico, Arizona, Nevada, Idaho, Oregon, Washington, and Alaska. Any type of insider, or employee, who possesses significant proof of their employer, or a government contractor defrauding the federal government is encouraged to contact to Corporate Whistleblower Center anytime at 866-714-6466, or they can contact the group via their web site at http://CorporateWhistleBlowerCenter.Com
For attribution purposes please review the United States Department of Justice Press release dated May 13th, 2013: http://www.justice.gov/opa/pr/2013/May/13-civ-542.html
Case number: United States v. Ranbaxy Laboratories, Ltd., et al. , Case No. JFM-12-250 (D. Md).